Vatanen A, Hou M, Huang T, Söder O, Jahnukainen T, Kurimo M, Ojala T H, Sarkola T, Turanlahti M, Saarinen-Pihkala U M, Jahnukainen K
Division of Hematology-Oncology and Stem Cell Transplantation, Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Department of Women's and Children's Health, Karolinska Institute and University Hospital, Stockholm, Sweden.
Bone Marrow Transplant. 2017 Apr;52(4):600-605. doi: 10.1038/bmt.2016.334. Epub 2017 Jan 9.
The aim of this study was to analyze the prevalence of frailty and physical health limitations among long-term survivors of high-risk neuroblastoma (HR NBL) and to investigate whether frail health is associated with variables of cardiovascular function, markers of inflammation and telomere length. A national study cohort of 19 (median age 22, range 16-30 years) long-term (>10 years) HR NBL survivors was studied and the findings were compared with 20 age- and sex-matched controls. Frailty was defined as ⩾3 of the following conditions: low muscle mass, low energy expenditure, slow running and weakness. The prevalence of frailty was significantly higher among the HR NBL survivors 9/19 (47%) than among the controls (0%). Thirteen (68%) of the survivors reported significant physical health limitations in vigorous activities, as opposed to none of the controls. The HR NBL survivors had significantly shorter telomere length and higher serum levels of high sensitivity C-reactive protein than did the controls. Frail health and poor physical functioning are prevalent among HR NBL survivors and suggest premature aging. Survivors with gonadal damage, very low fat mass percentage, low glycosylated hemoglobin A1c and increased common carotid artery intima-media thickness may be more prone to early aging after high dose therapy.
本研究旨在分析高危神经母细胞瘤(HR NBL)长期幸存者中衰弱和身体健康受限的患病率,并调查衰弱健康状况是否与心血管功能变量、炎症标志物和端粒长度相关。对一个由19名(中位年龄22岁,范围16 - 30岁)长期(>10年)HR NBL幸存者组成的全国性研究队列进行了研究,并将结果与20名年龄和性别匹配的对照组进行比较。衰弱被定义为具备以下⩾3种情况:低肌肉量、低能量消耗、跑步速度慢和虚弱。HR NBL幸存者中衰弱的患病率9/19(47%)显著高于对照组(0%)。13名(68%)幸存者报告在剧烈活动中存在显著的身体健康受限,而对照组无一例出现这种情况。HR NBL幸存者的端粒长度显著短于对照组,且血清高敏C反应蛋白水平高于对照组。衰弱健康状况和身体功能不佳在HR NBL幸存者中普遍存在,提示过早衰老。性腺受损、极低脂肪质量百分比、低糖化血红蛋白A1c以及颈总动脉内膜中层厚度增加的幸存者在高剂量治疗后可能更容易出现早衰。